| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Jan 25 | SAGE Sage Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 44,737 |
| 16 Jan 25 | SAGE Sage Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 6.97 | 40,000 | 278.80 k | 40,000 |
| 1 Nov 24 | SAGE Sage Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 6,250 | 0.00 | 24,737 |
| 1 Nov 24 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 6.05 | 12,500 | 75.63 k | 12,500 |
| 5 Aug 24 | SAGE Sage Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 8.96 | 4,755 | 42.60 k | 18,487 |
| 5 Aug 24 | SAGE Sage Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 16,200 | 0.00 | 23,242 |
| 13 Feb 24 | SAGE Sage Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 13,500 | 0.00 | 19,430 |
| 13 Feb 24 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.02 | 27,000 | 621.54 k | 27,000 |
